文献速递炎症性肠病消化内镜

治疗前磁共振小肠造影表现可预测克罗恩病对TNF-α抑制剂的应答

Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-09-04

这项前瞻性纵向单中心研究纳入58例临床活动性克罗恩病患者(86个严重炎症肠段),基线及第14、46周行磁共振小肠造影(MRE)。第46周51/86(59.3%)个肠段严重病灶愈合,28/58(48.6%)例患者全部严重病灶愈合;基线回肠位置、爬行脂肪及第14周节段MaRIA>10.6可预测长期愈合。

要点

  • 基线MRE无爬行脂肪及回肠位置是长期严重炎症愈合的临床相关预测因素。
  • 第46周51/86(59.3%)个肠段严重病灶愈合,28/58(48.6%)例患者全部严重病灶愈合。
  • 第14周节段MaRIA评分>10.6持续存在是第46周愈合的阴性预测因素(OR 0.3)。

核心结论

  • 在克罗恩病患者中,基线MRE未检出爬行脂肪及严重炎症病灶的位置是TNF-α抑制剂治疗下长期严重炎症愈合的临床相关预测因素。

研究设计与样本

  • 前瞻性纵向单中心研究,纳入58例临床活动性克罗恩病需TNF-α抑制剂治疗且至少一个肠段MRE检出严重炎症病灶(节段MaRIA≥11)的患者。
  • 基线、第14周和第46周获取MRE数据,共分析86个严重炎症肠段。
  • 主要终点为每个肠段严重炎症病灶愈合(MaRIA<11),次要终点为按患者分析全部严重炎症病灶愈合。

主要发现

  • 第46周严重病灶愈合见于51/86(59.3%)个肠段,全部肠段炎症病灶完全愈合见于28/58(48.6%)例患者。
  • 多变量分析显示基线回肠位置(相对于结肠)是长期严重炎症愈合的阴性预测因素(OR 0.00,[0.00-0.56],P=0.002)。
  • 基线MRE存在爬行脂肪是长期严重炎症愈合的阴性预测因素(OR 0.00 [0.00-0.57];P=0.001)。
  • 第14周节段MaRIA评分>10.6持续存在是第46周愈合的阴性预测因素(OR 0.3 [0.04--0.38];P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identifying predictors of therapeutic response is the cornerstone of personalised medicine. AIM: To identify predictors of long-term healing of severe inflammatory lesions based on magnetic resonance enterography (MRE) findings in patients with Crohn's disease (CD) treated with tumour necrosis factor alpha (TNF-α) inhibitors. METHODS: This prospective longitudinal single-centre study included patients with clinically active CD requiring treatment with TNF-α inhibitors with at least one intestinal segment with a severe inflammatory lesion detected by MRE (segmental MaRIA ≥11). MRE data were obtained at baseline, and at weeks 14 and 46. The primary endpoint was healing of severe inflammatory lesions (MaRIA <11) in each segment. The secondary endpoint was healing of all severe inflammatory lesions on a per-patient analysis. RESULTS: We included 58 patients with 86 intestinal segments with severe inflammatory lesions. At week 46, healing of severe lesions was found in 51/86 (59.3%) segments, and complete healing of inflammatory lesions in all segments was found in 28/58 (48.6%) patients. Multivariable analysis found baseline-negative predictors of long-term healing of severe inflammation were ileal (as opposed to colonic) location (OR 0.00, [0.00-0.56] P = 0.002) and presence of creeping fat on MRE (OR 0.00 [0.00-0.57]; P = 0.001). Persistence of segmental MaRIA score >10.6 at week 14 was a negative predictor of healing at week 46 (OR 0.3 [0.04--0.38]; P < 0.001). CONCLUSION: In patients with CD, the absence of creeping fat detected at baseline MRE and location of severe inflammatory lesions are clinically relevant predictors of long-term healing of severe inflammation under treatment with TNF-α inhibitors.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Rimola J, Fernàndez-Clotet A, Capozzi N, et al. Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease. Aliment Pharmacol Ther. 2020. PMID: 32886809. doi:10.1111/apt.16069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。